SAFE obtains a favorable opinion for its recovery plan

At the hearing on October 18, 2024 at the Paris Commercial Court, the Safe group, specializing in medical devices for spinal surgery, received a favorable opinion regarding its recovery plans. This positive decision, which concerns Safe SA as well as its subsidiaries Safe Orthopaedics and Safe Medical, is crucial for the future of the group. The decision will be rendered from November 5. In the meantime, Safe undertakes to keep the market informed of developments in the procedure.

Safe Group, with approximately 100 employees, is recognized for its innovation in ready-to-use technologies, including SteriSpineTM kits, used in minimally invasive surgery. The group has a presence in France, the United Kingdom, Germany and the United States.